Skip to main content
S 2313 110th Congress Senate Health Authorization Bacterial diseases Department of Health and Human Services Drug resistance in microorganisms Drugs Economics and Public Finance Executive reorganization Federal advisory bodies Government Operations and Politics Government paperwork Government publicity Health surveys Medical research Science, Technology, Communications

Strategies to Address Antimicrobial Resistance Act

Introduced: November 6, 2007 See on congress.gov
This bill died when the 110th Congress ended
It never became law before the 110th Congress (2007–2008) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 6, 2007
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Nov 6, 2007
Introduced in Senate
Nov 6, 2007
Sponsor introductory remarks on measure. (CR S13996)
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Strategies to Address Antimicrobial Resistance Act - Amends the Public Health Service Act to direct the Secretary of Health and Human Services to: (1) establish, and appoint the Director of, the Office of Antimicrobial Resistance to develop plans for addressing antimicrobial resistance in the United States and internationally; (2) establish the Public Health Antimicrobial Advisory Board to assist the Director; and (3) develop an antimicrobial resistance strategic research plan. Renews the Antimicrobial Resistance Task Force and sets forth its membership and duties.

Amends the Federal Food, Drug, and Cosmetic Act to require the submission of human and animal drug distribution data to the Office of Antimicrobial Resistance, the Antimicrobial Resistance Task Force, and the Public Health Antimicrobial Advisory Board. Requires the Director to make drug distribution data publicly available by antimicrobial drug class.

Requires the Secretary to establish at least 10 Antimicrobial Resistance Clinical Research and Public Health Network sites to describe outbreaks of antimicrobial resistant pathogens and monitor the patterns of such pathogens in individuals.

What's happening now November 6, 2007

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2313: Strategies to Address Antimicrobial Resistance Act. 110th Congress. Open America. https://openamerica.io/bill/110-S-2313/
MLA
"S. 2313: Strategies to Address Antimicrobial Resistance Act." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-S-2313/.
Bluebook (legal)
S. 2313, 110th Cong. (2026), https://openamerica.io/bill/110-S-2313/.
Markdown link
[S. 2313: Strategies to Address Antimicrobial Resistance Act](https://openamerica.io/bill/110-S-2313/)
Report a problem